Organization

Hospital Universitario La Fe

2 clinical trials

2 abstracts

Abstract
Survival outcomes in ALK-positive NSCLC patients (p) treated 1st line brigatinib and impact of the ALK fusion variant.
Org: Hospital Universitario Puerta de Hierro-Majadahonda, Hospital Universitario A Coruña, Son Espases University Hospital, Hospital Regional Carlos Haya, Catalan Institute of Oncology-Hospitalet,
Abstract
ANAKINRA PLUS STANDARD OF CARE FOR THE REDUCTION OF HYPERINFLAMMATION AND RESPIRATORY DISTRESS IN PATIENTS WITH SARS-COV-2 INFECTION: A MULTICENTRE, RANDOMISED, OPEN-LABEL PHASE 2/3 TRIAL (ANA-COVID-GEAS STUDY)
Org: Hospital Universitario de Navarra, Hospital Universitario Clínico Lozano Blesa, Hospital de Cabueñes, Hospital La Paz, Hospital Ramón y Cajal,